Skin health patent issued

4/11/2018: The US Patent office issued # 9,925,152 B2 on March 27, 2018. This was a continuation of the parent patent 9,498,413 which claimed protocatechuic acid as a broad spectrum antibiotic and a wound healing accelerator.

The additional claims indicated the collagen formation properties and potential to reduce scar formation. The clinical application may accompany cosmetic exfoliation and surgical dermabrasion yielding a form of skin wrinkle treatment.

See these granted claims.

10. The method of claim 1 wherein the treating of the wound is a cosmetic method of treating skin to enhance skin healing, wherein the composition is administered topically, orally or by intradermal or subcutaneous injection to a skin tissue, wherein the composition promotes an effect selected from the group consisting of reducing inflammation, optimizing growth hormone production, and increasing collagen stimulation.

11. The method according to claim 1, wherein said administration further results in reduced scar formation.